InsiderTrades

Form 4 for CC Chemours Co

Accepted 2022-05-06 00:00:00 ET · period of report 2022-05-05 · accession 0001627223-22-000036 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-05-06 2022-05-05 CC Bellezza Alisha Pres, Thermal Spec Solns M - OptEx $18.07 +14.4K 47.7K +43% +$259.5K
DM 2022-05-06 2022-05-05 CC Bellezza Alisha Pres, Thermal Spec Solns S - Sale+OE $40.48 -14.4K 38.8K -27% -$581.5K
DM 2022-05-06 2022-05-05 CC Bellezza Alisha Pres, Thermal Spec Solns M - OptEx $0.00 -14.4K 10.9K -57% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-05 M A 5,453 $24.01 44,250.34 D — — (F1) Includes directly owned shares, restricted stock units and dividend equivalent units.
2 Common Common Stock 2022-05-05 M A 8,912 $14.43 47,709.34 D — — (F1) Includes directly owned shares, restricted stock units and dividend equivalent units.
3 Common Common Stock 2022-05-05 S D 8,912 $40.48 38,797.34 D — — (F2) Shares were sold in multiple transactions at prices ranging from $40.46 to $40.56. (F1) Includes directly owned shares, restricted stock units and dividend equivalent units.
4 Common Common Stock 2022-05-05 S D 5,453 $40.48 38,797.34 D — — (F2) Shares were sold in multiple transactions at prices ranging from $40.46 to $40.56. (F1) Includes directly owned shares, restricted stock units and dividend equivalent units.
5 Derivative Stock Option (Right to Buy) 2022-05-05 M D 8,912 $0.00 8,912 D $14.43 · — to 2030-03-02 8,912 Common Stock (F3) Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.
6 Derivative Stock Option (Right to Buy) 2022-05-05 M D 5,453 $0.00 10,906 D $24.01 · — to 2031-03-01 5,453 Common Stock (F4) Option award was granted on March 1, 2021 with vesting in three equal annual installments beginning March 1, 2022.